|
|
|
Jewish World Review July 28, 2003 / 28 Tamuz, 5763
By Robert A. Wascher, M.D., F.A.C.S.
http://www.NewsAndOpinion.com |
Prostate cancer is the second leading cause of cancer death among men in the United States. Among all risk factors associated with prostate cancer, age is, by far, the greatest risk factor: more than 95% of all cases of prostate cancer occur in men over the age of 55. Family history and race have also linked as risk factors. Men with first-degree relatives who have been diagnosed with prostate cancer are at increased risk themselves. African American men have a higher incidence of prostate cancer than men from other ethnic backgrounds, while Native American men have the lowest incidence of the disease.
In recent years, the PSA blood test has become a routine part of annual physical examinations for many men over the age of 50. The test detects a protein that is secreted almost exclusively by the prostate gland, a walnut-sized structure that wraps around the male urethra at the base of the bladder. In general, the higher the PSA level, the greater the chance that a patient actually has prostate cancer. In men aged 50 and over, a PSA level of 4 to 10 ng/ml translates into a 25% statistical likelihood of having prostate cancer. When the PSA level exceeds 10 ng/ml, the risk of having prostate cancer increases to about 60%.
Among men with clinically detectable prostate cancer, approximately 70% will have an elevated level of PSA in their blood, while the remaining 30% will have a normal PSA level. Conversely, in 12-15% of men over the age 50, PSA levels are elevated (> 4ng/ml) in the absence of any prostate cancer. These limitations of the PSA test, expressed as the false negative and false positive rates, respectively, have engendered a great deal of controversy about the accuracy and appropriateness of the test. Indeed, many prominent prostate cancer experts take the position that the PSA test is too prone to erroneous interpretation to justify its routine use as a cancer screening test. Other experts correctly point out that, for all of its inherent limitations, the PSA test is still the best and only blood test available to clinicians and patients for prostate cancer screening, and that the detection rates of prostate cancer have increased significantly since the test's introduction in 1986.
A false positive PSA test occurs when a patient without prostate cancer is found to have an elevated PSA level in his blood. Since PSA is secreted by both normal and malignant cells within the prostate, several non-malignant conditions can give rise to a false positive PSA test. The gradual enlargement of the prostate gland (BPH, or benign prostatic hypertrophy) that occurs with normal aging can result in an elevated PSA, although the elevated PSA levels for men with BPH will usually remain in the 4-10 ng/ml range. Other causes of false positive PSA tests include prostatitis (inflammation or infection of the prostate gland), urinary tract infections, instrumentation of the urinary tract or rectum, and surgical procedures in the vicinity of the prostate gland.
Due to the shortcomings of the PSA test, as already described, the relatively high incidence of false positive PSA tests results in a great deal of anxiety and unnecessary medical procedures for a large number of men every year. In view of this, some experts have advocated that men with mild elevations in their PSA levels, and who are without evidence of prostate cancer by rectal examination or prostate biopsy, should undergo a more specialized type of PSA test called "free PSA." Excessive blood levels of PSA caused by benign prostate diseases tend to occur in the "free" form. That is, the PSA molecule is not bound to another protein that acts as a carrier for PSA in the blood. In prostate cancer, however, there is a greater tendency for PSA to be secreted by malignant prostate cells in the "bound" form. Thus, additional discriminatory information may be obtained by comparing free and bound PSA levels. Unfortunately, even this approach is not 100% accurate in making or excluding the diagnosis of prostate cancer. Another diagnostic approach to questionable cases of prostate cancer includes PSA velocity measurements, which are used to assess the rate of increase of PSA levels over a period of time. Rapidly rising PSA levels over a brief time interval suggests prostate cancer, while minimal PSA rise over time suggest either benign prostate disease or a very slow-growing prostate cancer.
A false negative PSA test occurs when a patient with prostate cancer is found to have a normal PSA level. Unfortunately, such false negative PSA tests occur in nearly one-third of men with prostate cancer. Careful and repeated examinations of the prostate, serial PSA tests, and a low threshold to perform a prostate biopsy should all be considered if there is some reason for continued clinical suspicion of prostate cancer despite a normal PSA test.
Perhaps the most noncontroversial application of the PSA test is to monitor patients with a history of prostate cancer, and prostate cancers associated with an elevated PSA at initial diagnosis in particular, for early evidence of recurrence. Although hormonal therapies for prostate cancer can lower PSA levels in the blood even in the face of persistent or recurrent prostate cancer, the PSA test is very often the first indication of disease recurrence.
Until a more sensitive and specific screening test for prostate cancer comes along, the PSA test, despite its many imperfections, is still the best screening test currently available.
In view of the PSA-related controversies that I have just discussed, an interesting study in the current issue of the New England Journal of Medicine is worthy of discussion. In this study, a total of 6,691 men underwent PSA testing between 1995 and 2001. Among these men, 705 (11%) eventually underwent biopsy of the prostate gland because of elevated PSA levels or other clinical findings. The authors then compared PSA levels in the blood of the men who were confirmed to have prostate cancer with the levels in those men who were found not to have prostate cancer. Their analysis was designed to assess the predictive value of the currently accepted normal PSA cut-off value of 4 ng/ml.
The authors of this study concluded that setting the normal PSA cut-off value at 4.1 ng/ml would have missed 65% of the prostate cancers in men 60 years of age and older, while a whopping 82% of prostate cancers would have been missed in men who were less than 60 years of age. If the threshold of normal vs. abnormal PSA level was decreased to 2.6 ng/ml, the authors calculated that the prostate cancer detection rate for men under age 60 would have doubled, to about 36%. However, this improved detection sensitivity would have come at the cost of a tripling of prostate biopsies, from 2% to about 6%.
This study, frankly, only increases the controversy regarding the role of PSA testing as a cancer screening assay. For all of its potential, PSA testing has still not been definitively shown to improve survival rates for prostate cancer. As I discussed in last week's column, prostate cancer, in most men, is a relatively slow-growing disease. It occurs most frequently in elderly men, and is seldom the cause of death in these patients. At the same time, prostate cancer will be newly diagnosed in nearly a quarter of a million men this year, and close to 30,000 men will die of the disease in 2003. By one expert's estimation, 80 American men will die of prostate cancer over the next 24 hours. While imperfect, at best, it would appear that the PSA test is our most useful screening tool until something better comes along. Based upon this latest study, the threshold value for a normal PSA test will probably be adjusted downward somewhat, although at the expense of more unnecessary prostate biopsies.
JWR contributor Dr. Robert Wascher is an oncologic surgeon, professor of surgery, oncology research scientist, and author. He lives in Honolulu with his wife and two daughters.
Comment by clicking here.
Accuracy of Prostate-specific Antigen (PSA) Test
07/22/03: Overgrowth of the Brain in Early Life; Finasteride & Prostate Cancer
07/11/03: Green Tea Extract & Cholesterol; Walking, Diabetes & Death; Update on Colon Cancer Screening; more
07/01/03: The Mediterranean Diet & Health; Effects of Long-term Hormone Replacement Therapy; More Nails in the HRT Coffin
06/10/03: Leisure Activities & the Risk of Dementia; New MRI Detects Tiny Prostate Cancer Lymph Node Metastases; Soy Intake & Breast Cancer Risk in Japan; Prozac & Premature Ejaculation
06/10/03: Working the Night Shift & Your Risk of Cancer; Your Personality & the Risk of Cancer; Spinal Manipulation for Low Back Pain; Movies, Teenagers & Smoking
06/02/03: Vindication for Dr. Atkins…?; Hospital Volume & Colostomy Rates for Rectal Cancer Surgery; Hormone Replacement Therapy: Another Nail in the Coffin
05/19/03: Internet & e-mail use for health care purposes; more news on physical inactivity & cancer risks; reversal of systemic lupus erythematosus; autologous bone marrow cells improve chronic heart failure
05/13/03: Vaccinations & Multiple Sclerosis; Emergency treatment of Bleeding Esophageal Varices; the deconstruction of the hormone replacement therapy myth continues
05/05/03: Vitamins & Colorectal Cancer; Unnecessary Prescribing of Antibiotics in Hospitals; Relationships between Bullying & Violent Behavior among Students; Pneumococcal Vaccine Update; Long Chain Fatty Acids in Infant Formula & Blood Pressure; Physical Activity & the Risk of Breast Cancer in Asian-American Women
04/28/03: Body Weight & the Risk of Cancer; Bone Protection Following Discontinuation of Hormone Replacement Therapy; C-reactive Protein & Stroke
04/14/03: Echinacacea & Quality Control; Obesity Update; Aortic Valve Stenosis, Arteriograms & Strokes; Preventing Recurrent Blood Clots
03/31/03: Breast Fibroadenomas & the Risk of Breast Cancer; Inflammatory Markers & Risk of Heart Failure; Update on Smallpox Vaccine; SARS Update
03/10/03: More Data on Hormone Replacement Therapy & the Risk of Breast Cancer; Oral Health & the Risk of Cardiovascular Disease; More Bad News about C-reactive Protein; Update: Daily Multivitamin & Minerals Supplements; Baby Aspirin & the Risk of Colorectal Adenomas; Aspirin & the Risk of Colorectal Polyps
03/03/03: Management of enlarging thyroid nodules; Long-term anticoagulation reduces the risk of recurrent blood clots in the veins; colon polyp recurrence after colonoscopic polyp removal; Vitamins C & E and Atherosclerotic Disease: The Debate Continues
02/24/03: Tamoxifen & Benign Breast Disease; New Recommendation on Digitalis Dosing; Creutzfeldt-Jakob Disease & the Nose; Radiologist Experience & Accuracy of Mammogram Interpretation; More Data on the Incidence of GI Side Effects with Selective COX-2 NSAIDs; Regular Rest Breaks & the Risk of Industrial Accidents
02/18/03: Update on Alzheimer's Disease; Very Low Birth-weight Babies & Cognitive Development; The Great Blood Pressure Medication Debate
02/03/03: Update on C-reactive Protein; COX-2 Inhibitors & Arterial Function; COX-2 Inhibitors and Gastrointestinal Complications; Telomere Shortening & Risk of Death
01/24/03: Bo-tox that BO Away!; The Super-sizing of America; Marijuana: A Gateway Drug?
01/21/03: Dietary Soy & Prostate Cancer Risks; Retention of Surgical Foreign Bodies after Surgery; Diet & hormone levels in adolescent girls
01/10/03: Can Aspirin Prevent Esophageal Cancer?; A Drink to Your Health!; Hormones & Breast Cancer; The Impact of Obesity on Lifespan
01/06/03:"The Pill" for Males?; Obesity & Diabetes Trends in the United States; Binge Drinking in the United States; One Less Reason to be Depressed; Liver Failure: Trends
12/20/02: Citrus Pectin & Cancer; Echinacea & the Common Cold; Update on High Blood Pressure Treatment
12/06/02: Calcium Intake & Prostate Cancer Risk; Alcohol Consumption & Risk of Breast Cancer; Reducing Blood Transfusions in Critically Ill Patients
12/06/02: Alcohol, Tamoxifen & Carotid Artery Wall Thickness; Coffee & Gallstones?; Irritable Bowel Syndrome Update; Statins: More Good News
11/22/02:Alcohol, HRT & the risk of breast cancer; hormone replacement therapy: more bad news; new vaccines may eliminate cervical cancer; more
11/15/02: The Effects of Diet & Exercise on Blood Pressure & Health; Growth Hormone & Sex Steroid Supplements & the Elderly; C-Reactive Protein & Cardiovascular Disease Risk
11/08/02: More Good News About Statin Drugs; Hormone replacement Therapy (HRT) & Alzheimer's Disease; A Role for Antibiotics in the Treatment of Vascular Disease?; more
11/01/02: Digoxin & gender; driving & degenerative disc disease; Coenzyme Q10 & Parkinson's Disease; Ginseng & erections; Viagra & stroke
10/25/02: Aspirin & coronary artery bypass surgery; glucosamine sulfate & progression of knee arthritis; hospital nurse staffing & patient mortality
10/18/02: Motor Vehicle Exhaust Pollution & Mortality; CT Scans, C-Reactive Protein & Heart Disease; Antiperspirant Use & the Risk of Breast Cancer; Atomic Bomb Radiation Exposure Update; more
10/04/02: Antioxidants & the Risk of Stomach Cancer; Best Way to Diagnose Appendicitis?; Coronary Artery Disease: Stent or Surgery?
09/27/02: Breast Feeding & the Risk of Asthma; HMOs & Quality of Care Scores; Red Wine & Vascular Disease
09/20/02: Dietary Folate & the Risk of Colorectal Cancer; Risks Associated with Smoking after Heart Attacks; BRCA1 Gene Mutation & the Risk of Breast & Non-breast Cancers; Breast Tissue Density & Inheritance
09/13/02: Dairy Products, Calcium, Vitamin D & the Risk of Breast Cancer; Efficacy of Nonprescription Smoking Cessation Aids; A Nutty Approach to Heart Disease Prevention; Update on Prostate Cancer
09/06/02: C-Reactive Protein & Estrogen Replacement Therapy; Walking Women & Cardiovascular Disease; Physical Activity Among Teenaged Girls
08/30/02: Babbling babies & brain function; homocysteine levels, vitamins & coronary artery disease; St. John's Wort & chemotherapy
08/16/02: A New Weapon Against Anthrax?; cataracts & motor vehicle accidents; gingko biloba takes a hit; air pollution & heart function during exercise; breast cancer genes & the estimated risk of breast cancer
08/09/02: Botulinum Toxin & Post-Stroke Spasticity; Intestinal Hormone Kills Appetite; Bone Marrow Cells Improve Blood Flow in Vascular Disease; Effectiveness of Restraining Orders on Domestic Violence
08/02/02: Mammography Saves Lives!; Obesity & the Risk of Heart Failure; High Sugar Diets & the Risk of Colon Cancer; Abuse During Childhood & Possible Effects of Genes on Antisocial Behaviors
07/26/02: Cancer: Nature vs. Nurture; Cardiorespiratory Fitness & Inflammation; Kidney Transplants from Cadaver Donors; Aircraft Cabin Air Recirculation & the Common Cold
07/19/02: PCBs & the Gender of Babies; Breastfeeding & the Risk of Breast Cancer; More Bad News About Hormone replacement Therapy
07/12/02: A cancer surgeon's perspective on hormone replacement therapy
07/08/02: Hormone replacement therapy & the risk of disease; more good news about statins; antioxidant vitamins & disease prevention; more
06/28/02: Antioxidants & the Risk of Alzheimer's Disease; Effects of Exercise on the Hearts of Patients with Mild Hypertension; Statins reduce cardiac events following angioplasty; more
06/21/02: Sex & violence and Advertising: Do Advertisers Get What they Pay For?; Don't Drink the Water (or the Salsa Either!); Vasectomy & Prostate Cancer Risk; Update on Smoking & Disease
06/14/02: Young Men, Obesity & Heart Disease; Breastfeeding & Obesity; Irritable Bowel Syndrome & rectal pain threshold; more data on cox-2 inhibitors & cancer; more
06/07/02: New coronary artery stent reduces risk of restenosis; possible cause of Parkinson's Disease identified; more
05/31/02: New biological insights into obesity & weight loss; broccoli kills cancer-causing stomach bug; anti-inflammatory drugs and the risk of heart attack
05/24/02: Molecular detection of tumor cells in the blood & prognosis; Cox-2 & breast/lung cancers; BRCA2 gene mutations & the risk of breast cancer; breast density & the risk of breast cancer
05/19/02: Moderate alcohol intake and blood sugar levels; more good news for tea drinkers; blood potassium levels & the risk of cardiovascular disease; ethnic differences in diabetic complications
05/10/02: Tea drinkers and the risk of death following heart attack; duration of breastfeeding & adult intelligence; abdominal aortic aneurysms: surgery or observation?
05/03/02: Risk of adverse drug reactions from newly released medications; preoperative beta-blockers may reduce heart bypass deaths; shape-shifting plastics may alter surgical practice; weight loss
supplement may cause liver damage
04/26/02: Angry young men & risk of premature cardiovascular disease; stay-at-home dads & risk of
cardiovascular disease; more on the effects of statins; dairy consumption and the risk of
pre-diabetes; smallpox vaccine: good to the last drop?
04/19/02: Change your sex by drinking water?; Anti-inflammatory RXs may reduce growth of breast cancer cells; radiation treatment reduces repeat narrowing of bypass grafts
04/05/02: Fish & Omega-3 fatty acid consumption and cardiac health; news briefs
04/05/02: Can coffee reduce your risk of tooth decay?; exercise & blood pressure; a single high-fat meal reduces coronary artery function
04/01/02: Pre-diabetes: a newly defined category of
health risk; teen television viewing and subsequent
aggressive behavior; the benefits of strength training
in the elderly; more ...
03/22/02: Bacteria, antibiotics & heart disease; mammograms: the debate continues; calcium & the risk of colon cancer ... and more
03/15/02: Mammography debate continues; statins & fracture risk; physical fitness & the risk of death; other intriguing findings
03/08/02: Blows to the chest & sudden cardiac death; air quality & the risk of lung cancer; tomatoes and your prostate
03/01/02: Diet & the risk of ovarian cancer; lifetime risk of developing high blood pressure; Osteoporosis prevention with a once-a-year injection?
02/26/02: The continuing controversy regarding screening mammography
02/22/02: Lowering body temperature after heart attack improves outcome; A silver lining for the chronically sleep-deprived?
02/15/02: Hormone replacement therapy & the risk of breast cancer; use it or lose it: Alzheimer's disease
& cognitive stimulation; stress, divorce & death; child daycare, infections & parental guilt
02/08/02: Possible breakthrough in early cancer diagnosis; mammography: the controversy continues; CPR techniques revisited
02/01/02: Antibiotics in livestock feed & human disease; genetic detection of early colon cancer in the stool; genetic analysis of breast cancers may help decide treatment
01/25/02: Drug increases lifespan (if you're a fly...); workplace attitudes and smoking cessation; effects
of inadequate sleep on surgeons
01/18/02: Lifelong effects of premature birth; smokers under the knife; aspirin and cardiovascular health
01/11/02: Estrogen levels in the blood & breast cancer risk; Heart attack: sex and survival; dangerous lettuce invaders
01/09/02: Cancer & aging: Two sides of the same coin?
01/04/02: Vitamin a & the risk of hip fracture in postmenopausal women; ovarian cancer risk and oral contraceptives
12/28/01:
Magnetic Resonance Imaging (MRI) detects
coronary artery disease; new development in
obesity research; adverse childhood experiences &
the risk of suicide attempts
12/21/01: Vaccination of children controls hepatitis a in the community; a possible cure for sickle cell disease; leptin and the risk of heart attacks
12/14/01: Chernobyl and the Risk of Thyroid Cancer in hildren; children & obesity; gastroesophageal reflux disease update
12/07/01: Update on school shootings; new implantable heart-assist device approved for further evaluation; prevention of fungal infections in pre-term babies
11/30/01: Flu vaccination in asthmatics; low-tar cigarettes are not less harmful; beans and your heart
11/21/01: Modified smallpox vaccine may reduce risk of cervical cancer; New approach to breast cancer diagnosis; New non-invasive prenatal diagnostic test for down's syndrome
11/16/01: Cholesterol-lowering drugs reduce risk of heart attack; supplemental radiation therapy reduces risk of breast cancer recurrence; brains of women may answer age-old questions
11/09/01: Bio-warfare (redux); my gray matter is bigger than yours; mad elk disease?
11/02/01: Making sense of bio-warfare
10/26/01: The impact of mammography on deaths due to breast cancer; diet & exercise may slow cancer cell growth; antidepressants and the risk of heart disease
10/19/01: New insights into autism; the wiley appendix
10/12/01: More bad news about obesity links to other diseases…Hey dad, can I borrow the car keys?
10/05/01: California leads nation in reduction of tobacco-related disease; exercise as an antidepressant?
09/25/01: Advances in the detection of breast cancer; primary care physician awareness of peripheral arterial disease; arsenic in the water
09/17/01: In perspective
09/12/01: Genes may hold secret to long life; men and women: cognitive function in the elderly; physical activity, obesity and the risk of pancreatic cancer
09/05/01: English milk cows prefer Beethoven and Simon & Garfunkel over
Bananarama; new prostate cancer prevention study: looking for a few good men; exercise & diet can help prevent diabetes
08/28/01: Arthritis drugs may be linked with increased risk of heart disease; errors in blood clotting tests can be fatal; infant soy formula not associated with reproductive side effects